• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Quantum-Si Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    6/24/26 4:06:09 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials
    Get the next $QSI alert in real time by email
    qsi-20260618
    0001816431FALSE00018164312026-06-182026-06-18

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 OR 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): June 18, 2026
    QUANTUM-SI INCORPORATED
    (Exact name of registrant as specified in its charter)

    Delaware
    001-39486
    85-1388175
    (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)
    29 Business Park Drive
    Branford, Connecticut
    06405
    (Address of principal executive offices)(Zip Code)
    Registrant’s telephone number, including area code: (866) 688-7374
    N/A
    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)
    Name of each exchange on
    which registered
    Class A common stock, par value $0.0001 per shareQSIThe Nasdaq Stock Market LLC
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company      o
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



    Item 1.01     Entry into a Material Definitive Agreement.

    On June 18, 2026 (the “Effective Date”), Quantum-Si, Incorporated, a Delaware corporation (the “Company”), entered into a lease agreement (the “Lease Agreement”) with Sterling City Science South Development, LLC, a Delaware limited liability company, (the “Landlord”), pursuant to which the Company will lease approximately 54,374 square feet (the “Rentable Area”) of planned office, laboratory and manufacturing space located at 9955 Pacific Heights Boulevard, San Diego, California, 92121 (the “Premise”).

    The Company entered into this lease in connection with the planned transition from its existing leased space in San Diego, California, which is expected to expire on December 31, 2027. The Premise is expected to include office, laboratory and manufacturing space and will be used to support the Company’s operations, including planned development activities related to its Proteus™ platform and expanded manufacturing capabilities.

    The Lease Agreement provides for a term of one hundred twenty (120) months from the commencement date, which is anticipated to be on or about September 1, 2027 (the “Commencement Date”), subject to the satisfaction of certain customary conditions and completion of planned tenant improvements, but in any event, will commence no later than November 1, 2027. The Company has the option to extend the term of the Lease Agreement for one additional period of five years, subject to the terms and conditions set forth therein.

    The Lease Agreement provides for initial monthly base rent of approximately $315,369.20 ($5.80/square foot of Rentable Area) for the first 12-month term (the “Base Rent”), which will increase by approximately 3% per each subsequent 12-month period on the anniversary of the Commencement Date over the term of the lease. In addition, the Company is responsible for certain operating expenses, taxes, and other charges specified in the Lease Agreement. Payments of monthly Base Rent for the Premise will be abated for months one (1) through twenty (20) after the Commencement Date. In addition, the Landlord will contribute up to $17,127,810.00 ($315.00/square foot of Rentable area) (the “Tenant Allowance”) toward the cost of tenant improvements (the “Tenant Improvements”), which the Company anticipates will cover the complete cost of the anticipated Tenant Improvements.

    Pursuant to the Lease Agreement, prepaid rent of $434,448.26 was payable by the Company upon execution of the Lease Agreement and will be applied to the first installment(s) of Base Rent due under the lease. A security deposit in the form of a letter of credit in an initial amount of $2,085,786.64 was also required as part of the Lease Agreement.

    In addition, within thirty (30) days following the Effective Date of the Lease Agreement, the Landlord shall provide a letter of credit to the Company in an initial amount of $19,475,890.00 to provide assurance that Landlord will have adequate funds available for the Tenant Allowance and will promptly pay applications for payment during the course of construction (or reimburse the Company for the approved payments it makes) to complete the Tenant Improvements.

    The foregoing description of the Lease Agreement does not purport to be complete and is subject to, and qualified in its entirety by, reference to the terms and conditions of the Lease Agreement, which is included as Exhibit 10.1 hereto.

    Forward-looking Statements

    Certain information discussed in this Current Report on Form 8-K is forward-looking information that involves risks, uncertainties and assumptions. Forward-looking statements may be identified by words such as “anticipate,” “believe,” “condition,” “expect,” “if,” “intend,” “may,” “will,” “planned” and similar expressions. Forward-looking statements in this Current Report relate to the Lease Agreement. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual plans or results to differ from our assumptions or expectations. Our risks are more fully described in our filings with the Securities and Exchange Commission, including our most recently filed Annual Report on Form 10-K, as updated in subsequently filed Quarterly Reports on Form 10-Q, as applicable. Forward-looking statements speak only as of the date they are made, and we expressly disclaim any obligation to update any forward-looking information.
    Item 2.03      Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.
    The information included in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.03 of this Current Report on Form 8-K. 



    Item 9.01      Financial Statements and Exhibits.
    (d)Exhibits.
    Exhibit
    No.
    Description
    10.1
    Lease agreement dated June 18, 2026, between Sterling City Science South Development, LLC and Quantum-Si Incorporated.*
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)

    *Certain exhibits or schedules to this exhibit have been omitted in accordance with Item 601(a)(5) of Regulation S-K. The registrant hereby agrees to furnish supplementally a copy of any omitted exhibit or schedule to the SEC upon its request.



    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    QUANTUM-SI INCORPORATED
    By:
    /s/ Jeffry Keyes
    Name:Jeffry Keyes
    Title:Chief Financial Officer
    Date: June 24, 2026

    Get the next $QSI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QSI

    DatePrice TargetRatingAnalyst
    2/7/2025$3.75Buy
    Alliance Global Partners
    12/8/2023$3.00Buy
    H.C. Wainwright
    9/25/2023$3.50 → $2.00Buy → Hold
    Canaccord Genuity
    10/20/2021$13.00Buy
    Canaccord Genuity
    More analyst ratings

    $QSI
    SEC Filings

    View All

    Quantum-Si Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Quantum-Si Inc (0001816431) (Filer)

    6/24/26 4:06:09 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SEC Form 25-NSE filed by Quantum-Si Incorporated

    25-NSE - Quantum-Si Inc (0001816431) (Subject)

    6/10/26 4:34:28 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SEC Form SD filed by Quantum-Si Incorporated

    SD - Quantum-Si Inc (0001816431) (Filer)

    5/22/26 4:08:24 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that the Compensation Committee of Quantum-Si's Board of Directors has granted 134,141 restricted stock units ("RSUs") to new employees under the Company's previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the "2023 Inducement Plan"). The RSUs were granted as an inducement material to the new employees becoming an employee of Quantum-Si in accordance with Nasdaq Listing Rule 5635(c)(4).The 2023 Inducement Plan is used exclusively for the grant of equity awards to in

    6/16/26 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced a partnership with Cell Signaling Technology ("CST") to advance and validate next-generation protein sequencing and analysis of post-translational modifications ("PTM") on the Proteus™ single-molecule protein sequencing platform. The partnership will focus on integrating CST's PTM detection and immunoaffinity enrichment expertise with Quantum-Si's Proteus workflows to enable site-resolved detection and quantitation of proteins and PTMs for research applications. CST is a leading supplier of high-quality re

    6/10/26 8:00:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Announces the Expansion of the Proteus™ Roadshow

    Multi-City Roadshow is Driving Awareness of Proteus and Developing Customer Funnel for Commercial Launch Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced the expansion of a roadshow designed to accelerate the education of the market on its Proteus platform and applications for protein sequencing. The roadshow includes information about the Proteus platform and application focus as well as data on applications for protein sequencing utilizing the Company's first-generation Platinum® Pro instrument. During the second quarter of 2026, the roads

    6/3/26 8:00:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dowdy Paula bought $104,450 worth of shares (109,890 units at $0.95), increasing direct ownership by 69% to 269,107 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    3/9/26 6:01:13 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Director Kummeth Charles R. bought $459,800 worth of shares (500,000 units at $0.92), increasing direct ownership by 141% to 855,000 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    3/9/26 6:01:59 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Chief Financial Officer Keyes Jeffry R. bought $43,465 worth of shares (50,000 units at $0.87), increasing direct ownership by 13% to 446,820 units (SEC Form 4)

    4 - Quantum-Si Inc (0001816431) (Issuer)

    8/13/24 6:01:25 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alliance Global Partners initiated coverage on Quantum-Si with a new price target

    Alliance Global Partners initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $3.75

    2/7/25 8:29:38 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    H.C. Wainwright initiated coverage on Quantum-Si with a new price target

    H.C. Wainwright initiated coverage of Quantum-Si with a rating of Buy and set a new price target of $3.00

    12/8/23 7:55:31 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Quantum-Si from Buy to Hold and set a new price target of $2.00 from $3.50 previously

    9/25/23 9:04:14 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Jafri Amir

    4 - Quantum-Si Inc (0001816431) (Issuer)

    5/20/26 4:05:29 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Director Makes Brigid

    4 - Quantum-Si Inc (0001816431) (Issuer)

    5/20/26 4:05:31 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SEC Form 4 filed by Director Kenny John P.

    4 - Quantum-Si Inc (0001816431) (Issuer)

    5/20/26 4:05:27 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Leadership Updates

    Live Leadership Updates

    View All

    Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced the appointment of Charles ("Chuck") Kummeth to the role of independent Chairman of the Board, effective May 27, 2024. Mr. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President and CEO of Bio-Techne. During Mr. Kummeth's tenure at Bio-Techne, he oversaw tremendous growth across all aspects of the business including annual revenue growth from $300M to over $1.1B, growth in the employee base from 800 to over 3,000, and the successful execution of 19 acquisitions, all while maintaining a 35% or better EBITDA level. Under Mr. Ku

    5/30/24 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing CompanyTM, today announced the appointment of Paula Dowdy, a senior executive with more than 35 years of experience across life sciences, enterprise software, and technology industries, to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240321183506/en/Paula Dowdy (Photo: Business Wire) Ms. Dowdy currently serves on the Board of Directors for SPT Labtech, a world leading lab automation tools company based in the UK and is an advisor at EQT Life Sciences, one of Europe's leading investors targeting innovative

    3/21/24 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Introduces World's First Next-Generation Protein Sequencer™ in Japan with Addition of New Distributor

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company™, today announced that it has entered into an agreement with a new distributor who will make the company's protein sequencing instrument, Platinum® available for the first time in Japan. TOMY Digital Biology Co., Ltd., a renowned importer and distributor with a rich history dating back to the 1950s, will distribute Quantum-Si's next-generation protein sequencer™ and associated consumables throughout Japan. "Working with Quantum-Si marks a pivotal moment for TOMY Digital Biology, aligning with our commitment to advancing life sciences. We're poised to empower Japanese researchers wit

    1/18/24 8:30:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Quantum-Si Incorporated

    SC 13D/A - Quantum-Si Inc (0001816431) (Subject)

    9/17/24 4:24:56 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Quantum-Si Incorporated

    SC 13G/A - Quantum-Si Inc (0001816431) (Subject)

    6/28/24 5:16:32 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    SEC Form SC 13G filed by Quantum-Si Incorporated

    SC 13G - Quantum-Si Inc (0001816431) (Subject)

    2/13/24 9:41:18 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    $QSI
    Financials

    Live finance-specific insights

    View All

    Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones

    Successful sequencing on integrated Proteus instruments and continued progress toward amino acid coverage and overall launch capabilities Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced financial results for the first quarter ended March 31, 2026. Press Release Highlights Successful sequencing on integrated Proteus™ instruments Sequenced first customer samples on a Proteus prototype system Current developmental sequencing kit detects 17 amino acids Multiple customer posters, pre-prints and manuscripts released during the quarter

    5/7/26 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026

    Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will report financial results for the first quarter 2026 on Thursday, May 7, 2026. Jeff Hawkins, President and Chief Executive Officer, and Jeff Keyes, Chief Financial Officer, will host a conference call to discuss financial results and provide a business update on the same day at 4:30 PM ET. Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, individua

    4/16/26 8:30:00 AM ET
    $QSI
    Industrial Machinery/Components
    Industrials

    Quantum-Si Reports Fourth Quarter and Full Year 2025 Financial Results

    Releases List Price of Proteus™ Platform Reiterates Proteus Development Program On Track for Year End 2026 Launch Quantum-Si Incorporated (NASDAQ:QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, today announced financial results for the fourth quarter and full year ended December 31, 2025. Press Release Highlights Reported fourth quarter revenue of $451,000 Reported on track development of the Proteus platform and related R&D programs to expand proteome coverage and enable broad PTM analysis capabilities Announced list price for Proteus of $425,000 Announced 2026 Financial Guidance

    3/3/26 4:05:00 PM ET
    $QSI
    Industrial Machinery/Components
    Industrials